LadRx Financials

LadRx Stock Summary

LadRx competes with NovaBay Pharmaceuticals, InMed Pharmaceuticals, GeoVax Labs, Phio Pharmaceuticals, and Protara Therapeutics. LadRx Corporation, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat patients with cancer. LadRx Corporation was incorporated in 1985 and is headquartered in Los Angeles, California. Ladrx Corp operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.

LadRx Key Financial Ratios

LadRx's financial ratios allow both analysts and investors to convert raw data from LadRx's financial statements into concise, actionable information that can be used to evaluate the performance of LadRx over time and compare it to other companies across industries.

LadRx Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining LadRx's current stock value. Our valuation model uses many indicators to compare LadRx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LadRx competition to find correlations between indicators driving LadRx's intrinsic value. More Info.LadRx is rated second overall in return on equity category among its peers. It also is rated second overall in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value LadRx by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for LadRx's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

LadRx Market Pulse

Along with financial statement analysis, the daily predictive indicators of LadRx help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of LadRx. We use our internally-developed statistical techniques to arrive at the intrinsic value of LadRx based on widely used predictive technical indicators. In general, we focus on analyzing LadRx OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build LadRx's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in unemployment. Note that the LadRx information on this page should be used as a complementary analysis to other LadRx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

If you are still planning to invest in LadRx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LadRx's history and understand the potential risks before investing.